| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.5 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |